Skip to content

Study · Measured the body's own peptide · 1996

1 result

Differentiating neuroblastoma of pituitary gland: neuroblastic transformation of epithelial adenoma cells. Case report.

Lach B, Rippstein P, Benott BG, Staines W

Journal of neurosurgery1 Nov 1996Cited by 25 (Europe PMC)

PMID8893739 (opens in a new tab)DOI10.3171/jns.1996.85.5.0953 (opens in a new tab)PepBankPUB-08893739
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelCase report or seriesOther

    In a 40-year-old woman with a pituitary tumor, the neuroblastoma was immunohistochemically positive for oxytocin.

    In plain wordsIn one woman with a pituitary tumor, the tumor cells made the body's own oxytocin.

    Peptide
    Oxytocin
    Outcome
    Not applicableOxytocin immunoreactivity in pituitary neuroblastoma
    Study

    n = 1

    Outcome group
    Endogenous peptide levels · Cancer

    Source sentences

    Summary
    which was immunohistochemically positive for synaptophysin, S-100 protein, and oxytocin.
    1 context sentence
    Summary · context
    The authors report the case of a 40-year-old woman with a 12-year history of irregular menses, amenorrhea, infertility, galactorrhea, a slightly elevated prolactin level, and a slowly growing pituitary adenoma.

    This result measures the body's own Oxytocin. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    11 Oct 2026, 20:03 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 02:53 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.